Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure
Related Experiment Video
Updated: Jun 20, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Tibor Szabo1, Stephan von Haehling, Dirk Habedank
1Applied Cachexia Research, Department of Cardiology, Campus Virchow-Klinikum, Charité-University Medical School, Berlin, Germany. tibor.szabo@charite.de
Insights
Impaired insulin sensitivity (Si) is common in chronic heart failure (CHF). Minimal modeling provides a superior assessment of Si in CHF patients compared to HOMA, FIRI, and QUICKI indices.
Area of Science:
- Cardiology
- Metabolic Health
- Physiology
Background:
- Impaired insulin sensitivity (Si) is prevalent in chronic heart failure (CHF), correlating with disease severity and prognosis.
- Current methods like HOmeostasis Model Assessment (HOMA), Fasting Insulin Resistance Index (FIRI), and QUick Insulin CheCK Index (QUICKI) rely on single-time fasting measurements.
- The comparative value of these indices against dynamic Si assessment in CHF remains unclear.
Purpose of the Study:
- To compare the discriminatory power of minimal modeling for Si assessment against HOMA, FIRI, and QUICKI in stable CHF patients.
- To evaluate the association of different Si assessment methods with clinical parameters and survival in CHF.
Main Methods:
- Insulin sensitivity (Si) was assessed in 105 stable CHF patients using minimal modeling.
- HOMA, FIRI, and QUICKI were calculated from fasting glucose and insulin levels.
- Body composition was analyzed using dual-energy X-ray absorptiometry; peak oxygen uptake and skeletal muscle strength were measured.
Main Results:
- All methods indicated impaired Si in CHF patients compared to controls.
- Minimal modeling-derived Si distinguished between NYHA classes and correlated with peak oxygen uptake and muscle strength.
- Minimal model-derived Si independently predicted survival in CHF patients, unlike HOMA, FIRI, and QUICKI.
Conclusions:
- HOMA, FIRI, and QUICKI offer semi-quantitative estimates of Si but have limited discriminatory power in CHF.
- Dynamic assessment of Si using minimal modeling is superior for quantitative evaluation and pathophysiological studies in CHF.
- Minimal modeling provides a more robust assessment of Si in CHF, correlating with disease severity and prognosis.
Background:
In chronic heart failure (CHF), impaired insulin sensitivity (Si) is frequently observed. It is associated with symptomatic status and poor prognosis suggesting an intrinsic role of Si within CHF pathophysiology. HOmeostasis Model Assessment (HOMA), Fasting Insulin Resistance Index (FIRI), and QUick Insulin CheCK Index (QUICKI) are based on single-time fasting glucose and insulin assessment. Their value and discriminatory power in comparison to dynamic range assessment of Si by minimal modelling are not well established.
Methods And Results:
In 105 patients with stable CHF (mean age 62 ± 1 years, peak VO(2) 18.2 ± 0.7 mL/kg/min, LVEF 28 ± 2%, mean ± SEM) Si was assessed by minimal modelling. HOMA, FIRI, and QUICKI were calculated from single-time point fasting glucose and insulin measurements. Detailed body composition was analyzed using dual-energy X-ray absorptiometry. All assessment methods showed impaired Si in CHF patients compared to healthy controls (n = 25). Yet, only minimal model-derived Si differentiated between NYHA classes (p = 0.0007). Further, minimal modelling was the only method to be directly associated with peak oxygen uptake and skeletal muscle strength. Model-derived Si predicted survival independently of established prognostic markers in CHF (RR 0.30 [95%CI 0.14-0.63]; p = 0.0016). In contrast, HOMA, FIRI and QUICKI did not show any of these qualities.
Conclusion:
HOMA, FIRI and QUICKI are surrogate estimates of Si with reduced discriminatory power in patients with CHF. While they are suitable to semi-quantitatively categorize impaired Si compared to normal values, the dynamic range assessment of Si by minimal modelling is superior for quantitative assessment of Si in pathophysiological studies.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management